Article
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
18 Jul 2019
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is the most common and among the deadliest of pancreatic cancers. Its five-year survival is only ~8%. Pancreatic cancers are a heterogeneous group of diseases, of which, PDAC is particularly aggressive. Like many other cancers, PDAC also starts as a pre-invasive precursor lesion (known as pancreatic intraepithelial neoplasia, PanIN), which offers an opportunity for both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
